GlassScriptPhysician profile
Tomislav Dragovich
NPI 1518979715
$8,473.95
in general payments reported to CMS, 2019-2025
18 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2022: $96.62 · 2023: $8,020 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,800 · Travel and Lodging: $1,031 · Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,800.00 |
| Travel and Lodging | $1,031.34 |
| Food and Beverage | $320.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $7,831.34 | 2023 | |
| Novocure INC. | $161.18 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $102.79 | 2023 | Imjudo |
| Roche Molecular Systems, INC. | $91.49 | 2019 | |
| Beigene USA, INC. | $86.30 | 2023 | Brukinsa |
| Intera Oncology, INC | $66.51 | 2025 | Intera |
| Eisai INC. | $45.03 | 2019 | |
| Pfizer INC. | $27.12 | 2019 | |
| Kite Pharma, INC. | $18.39 | 2019 | |
| Merck Sharp & Dohme LLC | $16.33 | 2019 | |
| Gilead Sciences, INC. | $15.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.13 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomislav Dragovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.